Mildred G. Sterz

Cyclosporine in systemic sclerosis. results of a forty‐eight–week open safety study in ten patients

Philip J. Clements, Peter A. Lachenbruch, Mildred G. Sterz et al. · Arthritis & Rheumatism · 1993 · 137 citations

Medicine, Pharmacology, Pharmacotherapy +10

Correlation of the degree of dyspnea with health‐related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: Results from the scleroderma lung study

Dinesh Khanna, Philip J. Clements, Daniel E. Fürst et al. · Arthritis & Rheumatism · 2005 · 134 citations

Medicine, Clinical Sciences, Internal Medicine +17

Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three‐year, parallel, randomized, double‐blind study

Daniel E. Furst, Philip J. Clements, Steven Hillis et al. · Arthritis & Rheumatism · 1989 · 119 citations

Medicine, Immunology, Pharmacotherapy +12

Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis

P. Clements, Michael D. Roth, Robert M. Elashoff et al. · Annals of the Rheumatic Diseases · 2007 · 91 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

A Semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis

Philip J. Clements, Peter A. Lachenbruch, Daniel E. Furst et al. · Arthritis & Rheumatism · 1991 · 80 citations

Medicine, Cardiology, Internal Medicine +6